F-group (family)

109.2.1.1 Prenyltrans

Ligands and drugs

288
Member domains
176
with ligand contacts (≤ 4 Å)
61.1% of members
163
with DrugDomain annotations
56.6% of members
118
with a DrugBank compound
41.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 109.2.1.1 belongs to X-group 109 Repetitive alpha hairpins, which binds 9.1 ligand superclasses per 20 proteins, broader than 82% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB07780FPPFarnesyl diphosphate41
DB08180MGM2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE37
DB07771FII[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID9
DB07227778L-7781238
DB07895HFPALPHA-HYDROXYFARNESYLPHOSPHONIC ACID7
DB04960JANTipifarnib3
DB07841—Geranylgeranyl diphosphate3
DB06448336Lonafarnib2
DB069532C52-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE2
DB07216736(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE2
DB01785DMADimethylallyl Diphosphate1
DB04160PPVPyrophosphoric acid1
DB04464—N-Formylmethionine1
DB08674U49(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE1
DB08676U66(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE1
DB09459TLAL-tartaric acid1
DB12234BMVBMS-2146621

Most frequently bound compounds

PDB ligandNameDomains in contact
ZNmetalZINC ION172
CLCHLORIDE ION51
FPPFARNESYL DIPHOSPHATE42
MGM2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE36
GERGERAN-8-YL GERAN21
CAmetalCALCIUM ION19
GRGGERANYLGERANYL DIPHOSPHATE17
FII[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID12
3FX(2R)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid11
7784-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE8
DPODIPHOSPHATE7
FARFARNESYL7
A1HZ4(5~{R})-5-(2-methoxyphenyl)-9-[(2~{R})-3,3,3-tris(fluoranyl)-2-methoxy-2-phenyl-propanoyl]-3,9-diazaspiro[5.5]undecan-2-one6
HFPALPHA-HYDROXYFARNESYLPHOSPHONIC ACID6
MGmetalMAGNESIUM ION6
3CX(2S)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid5
JAN6-[(S)-AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]-4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN-2(1H)-ONE4
3PZ(3R)-3-benzyl-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carbonitrile3
60I[4-[[3-(2,2-dimethylpropyl)-1~{H}-benzimidazol-2-yl]methyl]piperazin-1-yl]-(1,3,5-trimethylpyrazol-4-yl)methanone2
7TP5-{(3R)-3-(4-hydroxybenzyl)-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-7-yl}furan-2-carbaldehyde2